Role of IP-10 to Predict Clinical Progression and Response to IL-6 Blockade With Sarilumab in Early COVID-19 Pneumonia. A Subanalysis of the SARICOR Clinical Trial.
Trigo-Rodríguez M, Cárcel S, Navas A, Espíndola-Gómez R, Garrido-Gracia JC, Esteban Moreno MÁ, León-López R, Pérez-Crespo PMM, Alonso EA, Vinuesa D, Romero-Palacios A, Pérez-Camacho I, Gutiérrez-Gutiérrez B, Martínez-Marcos FJ, Fernández-Roldán C, León E, Caño AA, Corzo-Delgado JE, Perez-Nadales E, Riazzo C, de la Fuente C, Jurado A, Torre-Cisneros J, Merchante N.
Trigo-Rodríguez M, et al. Among authors: fernandez roldan c.
Open Forum Infect Dis. 2023 Mar 11;10(4):ofad133. doi: 10.1093/ofid/ofad133. eCollection 2023 Apr.
Open Forum Infect Dis. 2023.
PMID: 37035487
Free PMC article.